Artificial human tissues from cord and cord blood stem cells for multi-organ regenerative medicine: viable alternatives to animal in vitro toxicology

Altern Lab Anim. 2010 May;38(2):183-92. doi: 10.1177/026119291003800210.

Abstract

New medicinal products and procedures must meet very strict safety criteria before being applied for use in humans. The laboratory procedures involved require the use of large numbers of animals each year. Furthermore, such investigations do not always give an accurate translation to the human setting. Here, we propose a viable alternative to animal testing, which uses novel technology featuring human cord and cord blood stem cells. With over 130 million children born each year, cord and cord blood remains the most widely available alternative to the use of animals or cadaveric human tissues for in vitro toxicology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Testing Alternatives / standards*
  • Animals
  • Artificial Organs*
  • Ectoderm / cytology
  • Ectoderm / physiology
  • Endoderm / cytology
  • Endoderm / physiology
  • Fetal Blood / cytology
  • Fetal Blood / immunology
  • Fetal Blood / physiology*
  • Humans
  • Immune Tolerance
  • Infant, Newborn
  • Mesoderm / cytology
  • Mesoderm / physiology
  • Regeneration / physiology*
  • Stem Cells / cytology
  • Stem Cells / immunology
  • Stem Cells / physiology*
  • Umbilical Cord / cytology
  • Umbilical Cord / immunology
  • Umbilical Cord / physiology*